Dr. Malekzadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
Dept Of
New York, NY 10065Phone+1 212-639-7537Fax+1 212-717-3169
Education & Training
University of Arizona College of MedicineClass of 2013
Eastern Virginia Medical SchoolResidency, Surgery
Certifications & Licensure
CA State Medical License 2024 - 2026
NY State Medical License 2022 - 2026
VA State Medical License 2013 - 2024
DC State Medical License 2016 - 2022- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 227 citationsPilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L. Goff, Richard A. Morgan, James Chih-Hsin Yang, Richard M. Sherry, Paul F. Robbins
Journal of Immunotherapy. 2019-05-01 - 60 citationsAdoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Sanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, Sri Krishna, Zhiya Yu
Cancer Immunology Research. 2022-08-03 - 69 citationsAntigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens.Parisa Malekzadeh, Rami Yossef, Gal Cafri, Biman C. Paria, Frank J. Lowery
Clinical Cancer Research. 2020-03-15
Press Mentions
Peripheral Blood from Patients with Metastatic Solid Tumors Is A Source of p53-Reactive T CellsJanuary 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
